Industry Problem
Prices that change mid-intake. That's not a mistake. It's a strategy.
A growing number of telehealth brands advertise a low entry price — then introduce dose fees, platform charges, and pharmacy surcharges only after you're already in the system.
The hidden pricing game is one of the most common complaints in the GLP-1 telehealth space. Patients enter an intake expecting one price and discover the real cost only after completing a medical questionnaire, uploading photos, and waiting for a provider review — when it's psychologically harder to walk away.
Dose-based pricing surprises
Some programs advertise a starting dose price, then reveal that every titration step costs significantly more. You don't know your actual ongoing cost until you're already committed.
Platform fees buried in fine print
Membership fees, 'provider access fees,' and telehealth platform charges often aren't included in the advertised program price.
Intro offers with short expiration
A $99 first month sounds compelling until you learn it only includes a starter micro-dose and renews at $350+.
Insurance language as a distraction
Brands that mention insurance eligibility without being clear about cash-pay program costs add confusion, not clarity.